Operating Company Healthcare

Worldwide Clinical Trials

Research Triangle Park, North Carolina, United States

Formerly known as Catalyst Clinical Research, Catalyst Clinical Research LLC, Catalyst Clinical Research Merges with Ce3, Inc.

Worldwide Clinical Trials is a global CRO serving development-driven biopharmaceutical companies, supporting sponsors across every development phase from early-stage through Phase III registration trials. The company delivers therapeutically dedicated expertise across areas including neuroscience, oncology, rare disease, and internal medicine, and operates a flexible service model including full-service trial management and functional services via Worldwide Flex.

Focus Areas
Contract Research Organization (CRO), Clinical development services

Tracked deals

3

3 tracked deals across 2020-2023.

Recent pace

0

0 tracked deals announced in the last 12 months.

Deal mix

Addon

3 addon

Worldwide Clinical Trials Acquisition Volume by Year

Last 3 years

Acquisition volume by year Annual acquisition counts for the last 3 years for Worldwide Clinical Trials. 1 2020 1 2022 1 2023

Supporting Data

Recent Transactions

  • Catalyst Clinical Research Acquires Genpro Research
    July 20, 2023
    Buyer
    Catalyst Clinical Research
    Target
    Genpro Research
    Industry
    Healthcare Services
    Location
    Massachusetts, United States
    Type
    Addon

    Catalyst Clinical Research, a Wilmington, North Carolina-based CRO and portfolio company of QHP Capital, has acquired Genpro Research, a Massachusetts-based clinical research organization with staff in the US, India, and Ireland. The deal adds more than 120 India-based team members and strengthens Catalyst's capabilities in biometrics/biostatistics, medical writing, real-world evidence (RWE)/HEOR, and AI-enabled automation.

  • Catalyst Clinical Research Acquires Aptus Clinical
    May 4, 2022
    Buyer
    Catalyst Clinical Research, NovaQuest Capital Management, LLC
    Target
    Aptus Clinical
    Industry
    Healthcare Services
    Location
    Cheshire, United Kingdom
    Type
    Addon

    Catalyst Clinical Research, a portfolio company of NovaQuest Capital Management, has acquired U.K.-based Aptus Clinical to accelerate Catalyst's European expansion and broaden its oncology and early-phase clinical services. The deal creates a multi-region CRO operating across North America and Europe, increases Catalyst's patient reach by nearly 600 and lifts combined headcount to more than 800.

  • Catalyst Clinical Research Merges with Ce3, Inc.
    August 5, 2020
    Buyer
    Catalyst Clinical Research, NovaQuest Capital Management, LLC
    Target
    Ce3, Inc.
    Industry
    Healthcare Services
    Location
    Connecticut, United States
    Type
    Addon

    Catalyst Clinical Research, a NovaQuest-backed CRO headquartered in Wilmington, North Carolina, has merged with Ce3, Inc., an early-phase oncology-focused CRO based in Clinton, Connecticut. The transaction combines Ce3's 15+ years of oncology expertise with Catalyst's broader clinical development and technology capabilities to create a next-generation oncology-focused CRO (add-on to Catalyst's NovaQuest-backed platform).

Related Acquisition Pages

Healthcare Services Buyers & Acquisitions 3 tracked deals by Worldwide Clinical Trials. Acquisitions in Connecticut 1 tracked deal by Worldwide Clinical Trials. Acquisitions in Massachusetts 1 tracked deal by Worldwide Clinical Trials.

Related articles

Selling a company? Get in front of buyers like Worldwide Clinical Trials

Turn tracked acquisition activity into an outreach-ready buyer list.

Find buyers like these →